首页 › 自身免疫性疾病 › 伊利诺伊州 › Chicago
Chicago IL 自身免疫性疾病临床试验
13项针对 自身免疫性疾病的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
招募中2 期
- University of Chicago, Department of Medicine: Rheumatology, Chicago
Study of PTC844 in Participants With Active Rheumatoid Arthritis
招募中2 期
- Chicago Arthritis and Regenerative Medicine, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- The University of Chicago Medical Center, Chicago
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
招募中1/2 期
- Northwestern Memorial Hospital, Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
招募中1/2 期
- Northwestern University, Chicago
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
招募中1/2 期
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center - Accepting Adult and Adolescent Patients, Chicago
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
招募中2 期
- University of Chicago, Chicago
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
招募中1/2 期
- University of Illinois Hospital & Health Sciences System, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- 以及另外 2 项
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
招募中1 期
- Northwestern University, Chicago
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
招募中观察性研究欢迎健康志愿者
- University of Chicago Medical Center, Chicago
其他城市的 自身免疫性疾病试验
- Houston, TX21 项研究
- Washington, DC19 项研究
- New York City, NY19 项研究
- Philadelphia, PA17 项研究
- Durham, NC15 项研究
- Boston, MA13 项研究
- Los Angeles, CA12 项研究
- Atlanta, GA9 项研究
- Dallas, TX9 项研究
- Miami, FL8 项研究
- Milwaukee, WI8 项研究
- Cleveland, OH8 项研究
Chicago的其他研究
- 乳腺癌59 项研究
- 非小细胞肺癌59 项研究
- 癌症（所有类型）51 项研究
- 前列腺癌45 项研究
- 肺癌43 项研究
- 转移性癌症42 项研究
- 肥胖症40 项研究
- 卵巢癌36 项研究
- 结直肠癌32 项研究
- 卒中31 项研究
- 头颈鳞状细胞癌29 项研究
- 超重29 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。